MICHAEL N. MCCARTY LAW OFFICE PLLC for AMERICAN MEDICAL TECHNOLOGISTS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Medicare/Medicaid MMM
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.